{
    "Trade/Device Name(s)": [
        "SYNCHRON CX Delta Clinical System",
        "SYNCHRON CX Calibrator 1",
        "SYNCHRON CX Calibrator 2",
        "SYNCHRON CX Calibrator 3"
    ],
    "Submitter Information": "Beckman Coulter, Inc.",
    "510(k) Number": "K071280",
    "Predicate Device Reference 510(k) Number(s)": [
        "K950958"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGX",
        "JIX"
    ],
    "Summary Letter Date": "May 04, 2007",
    "Summary Letter Received Date": "May 07, 2007",
    "Submission Date": "May 4, 2007",
    "Regulation Number(s)": [
        "21CFR862.1225",
        "21CFR862.1150"
    ],
    "Regulation Name(s)": [
        "Creatinine test system",
        "Calibrator, Multi-Analyte Mixture"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Creatinine"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "SYNCHRON CX Delta Clinical System",
        "SYNCHRON CX CE",
        "CX PRO System"
    ],
    "Method(s)/Technology(ies)": [
        "Jaffe rate method"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Calibrator",
        "Reagent",
        "Analyzer"
    ],
    "Document Summary": "FDA 510(k) summary for SYNCHRON CX Delta Clinical System and CX Calibrators 1, 2, and 3 for quantitative determination of creatinine in human serum, plasma, or urine using the Jaffe rate method.",
    "Indications for Use Summary": "For quantitative determination of creatinine in human serum, plasma, or urine and for calibrating SYNCHRON CX Delta, CX CE, and CX PRO Systems.",
    "fda_folder": "Clinical Chemistry"
}